iifl-logo

Nippon India Pharma Fund IDCW

Nippon India Pharma Fund IDCW

Fund Name

Nippon India Mutual Fund

Scheme Name

Nippon India Pharma Fund IDCW

AMC

Nippon India Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

10-May-2004

Fund Manager

Sailesh Raj Bhan

Net Assets (Rs. cr)

8736.57

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Nippon India Pharma Fund IDCW - Nav Details

Nav Date

:  26-Aug-2025

NAV [Rs.]

:  119.7877

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

Nippon India Pharma Fund IDCW- NAV Chart

Nippon India Pharma Fund IDCW- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
0.03
-1.36
4.36
12.7
3.09
23.8
18.68
20.34
Category Avg
0.44
-0.59
5.62
13.22
5.21
25.34
19.28
17.01
Category Best
1.29
0.86
9.58
17.64
16.85
30.28
22.42
35.9
Category Worst
-0.48
-2.14
-1.44
7.21
-11.76
20.92
14.54
-1.34

Nippon India Pharma Fund IDCW- Latest Dividends

Record DateDividend %Bonus
21-Feb-20241000

Nippon India Pharma Fund IDCW- Investment Details

Min. Investment(Rs.)

5000

Increm.Investment(Rs.)

1000

In & Out

In

InName Of The CompanyNo Of Shares
Anthem Bioscienc10,58,503

Out

InName Of The CompanyNo Of Shares
--

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology12.2262563491,067.77
EquityDivi's Lab.Pharmaceuticals & Biotechnology7.551000031659.57
EquityLupinPharmaceuticals & Biotechnology5.932683991517.76
EquityCiplaPharmaceuticals & Biotechnology5.693200000497.47
EquityDr Reddy's LabsPharmaceuticals & Biotechnology5.693916074497.45
EquityApollo HospitalsHealthcare Services5.57648795486.46
EquityMedplus HealthRetailing3.863627277337.53
EquityVijaya Diagnost.Healthcare Services3.552886684310.33
EquityGlaxosmi. PharmaPharmaceuticals & Biotechnology3.31913226288.81
EquityGland PharmaPharmaceuticals & Biotechnology3.121320549272.66
EquityAjanta PharmaPharmaceuticals & Biotechnology3.02959323263.94
EquityAbbott IndiaPharmaceuticals & Biotechnology2.7068677236.28
EquityThyrocare Tech.Healthcare Services2.631733833229.88
EquityDr Lal PathlabsHealthcare Services2.38659112207.67
EquitySai LifePharmaceuticals & Biotechnology2.362555745206.61
EquityNarayana HrudayaHealthcare Services2.261029215197.11
EquityMankind PharmaPharmaceuticals & Biotechnology2.23757496194.46
EquityAurobindo PharmaPharmaceuticals & Biotechnology2.221702630194.06
EquityZydus Lifesci.Pharmaceuticals & Biotechnology2.222000632194.02
EquityJ B Chemicals &Pharmaceuticals & Biotechnology2.02999649176.86
EquityPfizerPharmaceuticals & Biotechnology1.89318249165.31
EquityAlkem LabPharmaceuticals & Biotechnology1.86323678162.84
EquityBioconPharmaceuticals & Biotechnology1.773953457154.73
EquitySanofi IndiaPharmaceuticals & Biotechnology1.54230272134.13
EquitySuraksha Diagno.Healthcare Services1.343896349117.26
EquityIpca Labs.Pharmaceuticals & Biotechnology1.33785412115.76
EquityTorrent Pharma.Pharmaceuticals & Biotechnology1.30303364113.51
EquitySanofi ConsumerPharmaceuticals & Biotechnology1.20213659104.86
EquityFortis Health.Healthcare Services1.08110388994.65
EquitySyngene Intl.Healthcare Services1.05128049291.42
EquityAnthem BiosciencPharmaceuticals & Biotechnology0.92105850380.35
EquityAkums DrugsPharmaceuticals & Biotechnology0.90151526478.68
EquityEmcure PharmaPharmaceuticals & Biotechnology0.7647027266.28
EquityIndoco RemediesPharmaceuticals & Biotechnology0.67183492458.32
EquityAstrazeneca PharPharmaceuticals & Biotechnology0.666256857.47
EquityOrchid PharmaPharmaceuticals & Biotechnology0.4249272736.48
EquityConcord BiotechPharmaceuticals & Biotechnology0.2311173819.74
Cash & Cash Equivalent
Net CA & OthersNet CA & Others-/-0.29024.90
Reverse RepoTREPS-/-0.26022.81
Cash & Cash EquivalentC C I-/-0.0000.15

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
6,17,875.24
Trustee/s:
Mr. A N Shanbhag - Associ, Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda, Mr. Takayuki Murai
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Sailesh Raj Bhan
Auditors:
Haribhakti & Co LLP Chart

OTHER INFORMATION

Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.